13F

BDTX BLACK DIAMOND THERAPEUTICS I

2026Q1 · CUSIP 09203E105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
98
Δ holders QoQ
-5
Breadth percentile
Top 78%
Whale holders
54
Δ whales
+1
Inst. holding value
$77M
New positions
18
Closed positions
23
Price momentum (1Q)
Put / Call
2/3

Breadth history (34 quarters)

2020Q1: Δ+64 · h=65 2020Q2: Δ+14 · h=79 2020Q3: Δ+7 · h=86 2020Q4: Δ+23 · h=109 2021Q1: Δ+6 · h=115 2021Q2: Δ-13 · h=102 2021Q3: Δ-2 · h=100 2021Q4: Δ-5 · h=95 2022Q1: Δ-8 · h=87 2022Q2: Δ-12 · h=75 2022Q3: Δ-5 · h=70 2022Q4: Δ-10 · h=60 2023Q1: Δ-9 · h=51 2023Q2: Δ+24 · h=75 2023Q3: Δ-1 · h=74 2023Q4: Δ+3 · h=77 2024Q1: Δ+12 · h=89 2024Q2: Δ+3 · h=92 2024Q3: Δ+4 · h=96 2024Q4: Δ-7 · h=89 2025Q1: Δ-2 · h=87 2025Q2: Δ+8 · h=95 2025Q3: Δ-4 · h=91 2025Q4: Δ+12 · h=103 2026Q1: Δ-5 · h=98 2020Q1: holders=65 2020Q2: holders=79 2020Q3: holders=86 2020Q4: holders=109 2021Q1: holders=115 2021Q2: holders=102 2021Q3: holders=100 2021Q4: holders=95 2022Q1: holders=87 2022Q2: holders=75 2022Q3: holders=70 2022Q4: holders=60 2023Q1: holders=51 2023Q2: holders=75 2023Q3: holders=74 2023Q4: holders=77 2024Q1: holders=89 2024Q2: holders=92 2024Q3: holders=96 2024Q4: holders=89 2025Q1: holders=87 2025Q2: holders=95 2025Q3: holders=91 2025Q4: holders=103 2026Q1: holders=98 -64 -32 +0 +32 +64 4583121 20Q120Q421Q322Q223Q123Q424Q325Q226Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2023Q2 Top 8% -32.5% +64.3%
2020Q1 Top 1% -26.8% -19.1%

Options Sentiment

Put holders
2
QoQ: -1
Call holders
3
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.75
EPS YoY
-1350.0%
Revenue (TTM)
$0.0B
Revenue YoY
-100.0%
Quarterly Revenue & EPS (4Y)
2024-03-31: $0M 2024-06-30: $0M 2024-09-30: $0M 2024-12-31: $0M 2025-03-31: $70M 2025-06-30: $0M 2025-09-30: $0M 2025-12-31: $0M 2026-03-31: $0M 2022-06-30: EPS -0.63 2022-09-30: EPS -0.60 2022-12-31: EPS -0.59 2023-03-31: EPS -0.57 2023-06-30: EPS -0.52 2023-09-30: EPS -0.45 2023-12-31: EPS -0.34 2024-03-31: EPS -0.35 2024-06-30: EPS -0.36 2024-09-30: EPS -0.28 2024-12-31: EPS -0.28 2025-03-31: EPS 0.98 2025-06-30: EPS -0.19 2025-09-30: EPS -0.15 2025-12-31: EPS -0.25 2026-03-31: EPS -0.16 0M 35M 70M $M -0.69 0.19 1.08 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 12 2025-03-31: PE 32.52025-06-30: PE 122025-09-30: PE 11.12025-12-31: PE 5.7 5 20 34 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)